10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb

A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial

(2011) Jens Kastrup et al.   EuroIntervention

Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats

(2010) Junming Tang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer

(2009) M Hedman et al.   GENE THERAPY

Intravitreal Adenoviral 15-Lipoxygenase-1 Gene Transfer Prevents Vascular Endothelial Growth Factor A-Induced Neovascularization in Rabbit Eyes

(2009) Helena Viita et al.   HUMAN GENE THERAPY

VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial

(2009) Duncan J Stewart et al.   MOLECULAR THERAPY

Ultrasound-Targeted Gene Delivery Induces Angiogenesis After a Myocardial Infarction in Mice

(2009) Hiroko Fujii et al.   JACC-Cardiovascular Imaging

Therapeutic Angiogenesis for Critical Limb Ischemia

(2008) Jörn Tongers et al.   CIRCULATION

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

(2008) Salima Hacein-Bey-Abina et al.   JOURNAL OF CLINICAL INVESTIGATION